These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10230056)

  • 1. Synthesis of 2-substituted-6,8-dichloro-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-1,1-d ioxides and -1-oxides as glycine-NMDA receptor antagonists.
    Varano F; Catarzi D; Colotta V; Filacchioni G; Cecchi L; Galli A; Costagli C
    Farmaco; 1998 Dec; 53(12):752-7. PubMed ID: 10230056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro.
    Boireau A; Monterrat C; Bordier F; Meunier M; Imperato A
    Eur J Pharmacol; 2000 Aug; 401(2):131-5. PubMed ID: 10924917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Hydroxy-6-oxo-6,7-dihydro-thieno[2,3-b] pyrimidine derivatives: synthesis and their biological evaluation for the glycine site acting on the N-methyl-D-aspartate (NMDA) receptor.
    Hwang KJ; Lee TS; Kim KW; Kim BT; Lee CM; Park EY; Woo RS
    Arch Pharm Res; 2001 Aug; 24(4):270-5. PubMed ID: 11534755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding characteristics of the novel NMDA receptor glycine site antagonist [3H]GV150526A in rat cerebral cortical membranes.
    Mugnaini M; Dal Forno G; Corsi M; Bunnemann B
    Eur J Pharmacol; 2000 Mar; 391(3):233-41. PubMed ID: 10729363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.
    Mugnaini M; Antolini M; Corsi M; van Amsterdam FT
    J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of five glycine site antagonists on NMDA receptor desensitisation.
    Molnár P; Erdõ SL
    Eur J Pharmacol; 1996 Sep; 311(2-3):311-4. PubMed ID: 8891614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides and their evaluation as ligands for NMDA receptor glycine binding site.
    Bluke Z; Paass E; Sladek M; Abel U; Kauss V
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):664-73. PubMed ID: 26114309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach.
    Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
    Arch Pharm (Weinheim); 1997 May; 330(5):129-34. PubMed ID: 9237424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity.
    Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
    J Med Chem; 1999 Jul; 42(13):2478-84. PubMed ID: 10395489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity.
    Jimonet P; Ribeill Y; Bohme GA; Boireau A; Chevé M; Damour D; Doble A; Genevois-Borella A; Herman F; Imperato A; Le Guern S; Manfré F; Pratt J; Randle JC; Stutzmann JM; Mignani S
    J Med Chem; 2000 Jun; 43(12):2371-81. PubMed ID: 10882363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro.
    Boireau A; Malgouris C; Burgevin MC; Pény C; Durand G; Bordier F; Meunier M; Miquet JM; Daniel M; Chevet T; Jimonet P; Mignani S; Blanchard JC; Doble A
    Eur J Pharmacol; 1996 Apr; 300(3):237-46. PubMed ID: 8739214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.
    Fray MJ; Bull DJ; Carr CL; Gautier EC; Mowbray CE; Stobie A
    J Med Chem; 2001 Jun; 44(12):1951-62. PubMed ID: 11384240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and of their constrained analogue imidazo.
    Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
    Eur J Med Chem; 2001 Feb; 36(2):203-9. PubMed ID: 11311751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists.
    Varano F; Catarzi D; Colotta V; Filacchioni G; Galli A; Costagli C; Carlà V
    J Med Chem; 2002 Feb; 45(5):1035-44. PubMed ID: 11855983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
    Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
    Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
    Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
    J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.
    Keana JF; Kher SM; Cai SX; Dinsmore CM; Glenn AG; Guastella J; Huang JC; Ilyin V; Lü Y; Mouser PL
    J Med Chem; 1995 Oct; 38(22):4367-79. PubMed ID: 7473565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.